Methamphetamine
| Obere ụdị nke | N-methylamphetamines  |
|---|---|
| Usoro kemịkalụ | C₁₀H₁₅N |
| SILES nke canonical | CC(CC1=CC=CC=C1)NC |
Methamphetamine bụ ọgwụ na- akpalị Central Nervous System (CNS) nke a na-ejikarị dị ka ọgwụ ntụrụndụ na nke na-adịkarịghị agwọ ọrịa hyperactivity nlebara anya, narcolepsy, na oke ibu.[1][2]. [3] Anaghịzi atụ aro iji ya maka oke ibu. [3] Mgbe ana-aṅụ ya n'ọnụ, mmetụta na-amalite n'ime nkeji iri atọ ma nwee ike ịdịru awa iri abụọ na anọ.[1]
Mmetụta ndị ọzọ a na-ahụkarị gụnyere ọbara mgbali elu, ịkụ aka, ọnọdụ dị elu, nsogbu ihi ụra, ịma jijiji, afọ ọsịsa, na Nsogbu mmekọahụ. [4][3] ndị ọzọ nwere ike ịgụnye isi mgbaka, ara, nkụchi, okpomọkụ dị elu, na tics. [1] E nwere oke ihe ize ndụ; ọ bụ ezie na ọnwụ site na iji ya eme ihe anaghị adịkebe. [3] [5]Iji ọgwụ ihe dịka n'oge ime nwere ike imerụ nwa ahụ ahụ ahụ, a naghị atụ aro ka a na-enye ya ara mgbe a na-eji ya eme ihe. [3] Ọ dị n'ezinụlọ ọgwụ amphetamine.
[1]A chọpụtara Methamphetamine na 1893 ma mepụta ya n'afọ 1919. [6] [1] na-emekarị ya n'ụlọ ọrụ iwu na-akwadoghị na United States na Far East. [1] [1]'oge ntụrụndụ, enwere ike ilo ya, bulie ya, gbaa ya ọgwụ, ma ọ bụ sie ya. [1] na-ahazi ya dị ka ihe a na-achịkwa na Ndepụta II. [1] [7] na-egbochi ma ọ bụ machibido mmepụta, nkesa, na inwe methamphetamine iwu n'ọtụtụ mba. [8] Na Europe ọ na-efu ihe dị ka 17 ruo 64 Euro kwa gram maka nnyefe iwu na-akwadoghị ka ọ na-erule 2018. Ihe [9] dika nde mmadụ iri abụọ na asaa jiri amphetamines, ọtụtụ n'ime ha bụ methamphetamine, n'afọ 2019.
Edensibia
[dezie | dezie ebe o si]- 1 2 3 4 5 6 7 "Methamphetamine". Drug profiles. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). 8 January 2015. Archived from the original on 15 April 2016. Retrieved 27 November 2018.
The term metamfetamine (the International Non-Proprietary Name: INN) strictly relates to the specific enantiomer (S)-N,α-dimethylbenzeneethanamine.
"Methamphetamine". Drug profiles. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). 8 January 2015. Archived from the original on 15 April 2016. Retrieved 27 November 2018.The term metamfetamine (the International Non-Proprietary Name: INN) strictly relates to the specific enantiomer (S)-N,α-dimethylbenzeneethanamine.
- ↑ "Recent advances in methamphetamine neurotoxicity mechanisms and its molecular pathophysiology". Behav. Neurol. 2015: 103969. March 2015. doi:10.1155/2015/103969. PMID 25861156.
{{cite journal}}: CS1 maint: article number as page number (link) CS1 maint: unflagged free DOI (link) - 1 2 3 4 5 "Methamphetamine Monograph for Professionals". Drugs.com (in Bekee). Archived from the original on 6 September 2021. Retrieved 18 November 2021.
- ↑ "Methamphetamine" (PDF). Archived from the original (PDF) on 23 June 2021. Retrieved 19 November 2021.
- ↑ "Methamphetamine". Drugs and Lactation Database (LactMed). National Library of Medicine (US). 2006. Archived from the original on 2 March 2021. Retrieved 19 November 2021.
- ↑ Mack, Avram H. (12 May 2016). Clinical Textbook of Addictive Disorders, Fourth Edition (in Bekee). Guilford Publications. ISBN 978-1-4625-2169-2. Retrieved 18 November 2021.
- ↑ Lilley, Linda Lane (20 January 2017). Pharmacology for Canadian Health Care Practice (in Bekee). Elsevier Health Sciences. ISBN 978-1-77172-022-9. Retrieved 19 November 2021.
- ↑ "Infographic: amphetamine, methamphetamine, seizures, price, purity in the EU, 2018 | www.emcdda.europa.eu". www.emcdda.europa.eu. Archived from the original on 13 November 2021. Retrieved 19 November 2021.
- ↑ World Drug Report 2021 (PDF). United Nations. 2021. ISBN 9789211483611. Retrieved 19 November 2021.
